Dyne Therapeutics, Inc. (DYN) vs Precigen, Inc. (PGEN)
A side-by-side comparison of Dyne Therapeutics, Inc. and Precigen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DYN
Dyne Therapeutics, Inc.
$15.17HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
PGEN
Precigen, Inc.
$7.65HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — DYN vs PGEN
growth of $100 · dividends reinvested · last 6yDYN -35.4% (-7.0%/yr)PGEN +46.5% (+6.6%/yr)PGEN compounded faster over this window
DYN PGEN
DYN vs PGEN: by the numbers
- •DYN is the larger company ($2.83B vs $2.73B market cap).
- •Both run net losses; DYN's is the smaller (0.00% vs -183.98% net margin).
Metrics side by side
Valuation
| Metric | DYN | PGEN |
|---|---|---|
| Forward P/E | N/A | 44.64 |
| P/S ratio | N/A | 31.82 |
| P/B ratio | 4.03 | 62.58 |
Profitability
| Metric | DYN | PGEN |
|---|---|---|
| Gross margin | 0.00% | 37.05% |
| Operating margin | 0.00% | -1100.78% |
| Net margin | 0.00% | -183.98% |
| ROE | -73.97% | -361.91% |
| ROIC | -58.28% | -28.02% |
Growth (annualized)
| Metric | DYN | PGEN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -21.26% |
| Total return CAGR (5Y) | -0.38% | 8.79% |
Frequently asked
- How have DYN and PGEN total returns compared?
- Over the past 5 years, DYN delivered -0.38% and PGEN delivered 8.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.